Semaglutide Repairs Kidney Blood Vessels, Study Finds
Researchers report the diabetes and obesity drug reduced kidney inflammation and improved blood flow in patients with chronic kidney disease.
Updated on Nov. 9, 2026 in Diabetes
A study published in Nature Medicine reports that semaglutide repaired blood vessels in the kidneys of patients with chronic kidney disease, reducing inflammation and increasing blood flow. The findings were published October 1, 2026.
Why it matters
Chronic kidney disease affects an estimated 674 million people worldwide, and diabetes and high blood pressure are among its most common causes. The results add to evidence about how semaglutide may protect kidney function beyond its established uses.
The analysis drew on kidney tissue from 106 trial participants, with samples compared before and after treatment against placebo. The source does not report whether these tissue changes will translate into long-term kidney outcomes.
The players
Nature Medicine
Nature Medicine is a peer-reviewed biomedical journal published by Springer Nature that publishes translational and clinical research.
The details
Researchers examined kidney tissue and found that semaglutide turned off genes linked to metabolic stress in the glomerulus and reduced inflammatory signaling from immune cells there. Participants taking the drug also showed less kidney scarring, reduced blood vessel stiffness and lower urine albumin levels.
Timeline
2024: The New England Journal of Medicine published a trial showing semaglutide reduced the risk of kidney failure and death in patients with diabetic chronic kidney disease.
October 1, 2026: Nature Medicine published the semaglutide kidney repair study.
Big Picture
The new findings build on a 2024 trial in which semaglutide reduced kidney failure and cardiovascular death in patients with diabetic chronic kidney disease. Together, the two studies point toward a protective role for the drug in kidney health.
The findings suggest semaglutide may help protect kidney function in patients with diabetes-related kidney disease, though the source does not address treatment decisions. Patients should discuss any kidney-related questions with their own clinicians.
The takeaway
Kidney health is closely tied to blood sugar and blood pressure management, and this research adds to the case for monitoring kidney function in people with diabetes. Readers with diabetes or high blood pressure can ask their doctors about routine kidney testing.
Further reading
For more on the conditions behind this research, see our Diabetes coverage.
Source note: This article includes information reported by Science News.
